Search research articles
Contact Us
Filters
Showing results (71-80 of 412) with videos related to
Page
of 42
Sort By:
Pathology Oncology Research : POR
|
September 13, 2011
Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma
Avninder Singh, Ashwani Kumar Mishra, Kris Ylaya, et al.
Pigment Cell & Melanoma Research
|
August 8, 2009
NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation
Kristina Buac, Mai Xu, Julie Cronin, et al.
Oncology Reports
|
January 5, 2007
Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray
Sherry X Yang, Stephen M Hewitt, Seth M Steinberg, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 16, 2014
Controls for immunohistochemistry: the Histochemical Society's standards of practice for validation of immunohistochemical assays
Stephen M Hewitt, Denis G Baskin, Charles W Frevert, et al.
Journal of Translational Medicine
|
May 8, 2016
Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients
Chel Hun Choi, Joon-Yong Chung, Jae-Hoon Kim, et al.
Journal of Pathology Informatics
|
August 23, 2013
Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer
Tyler Keay, Catherine M Conway, Neil O'Flaherty, et al.
Technology
|
June 2, 2015
Stain-less staining for computed histopathology
David Mayerich, Michael J Walsh, Andre Kadjacsy-Balla, et al.
Leukemia & Lymphoma
|
January 1, 2015
Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood
Carsten Hirt, M Constanza Camargo, Kelly J Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development
George Poste, David P Carbone, David R Parkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2015
CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma
Mary E Olanich, Wenyue Sun, Stephen M Hewitt, et al.
Page
of 42
Search research articles
Search
Showing results (71-80 of 412) with videos related to
Sort By:
Page
of 42
Pathology Oncology Research : POR
|
September 13, 2011
Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma
Avninder Singh, Ashwani Kumar Mishra, Kris Ylaya, et al.
Pigment Cell & Melanoma Research
|
August 8, 2009
NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation
Kristina Buac, Mai Xu, Julie Cronin, et al.
Oncology Reports
|
January 5, 2007
Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray
Sherry X Yang, Stephen M Hewitt, Seth M Steinberg, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 16, 2014
Controls for immunohistochemistry: the Histochemical Society's standards of practice for validation of immunohistochemical assays
Stephen M Hewitt, Denis G Baskin, Charles W Frevert, et al.
Journal of Translational Medicine
|
May 8, 2016
Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients
Chel Hun Choi, Joon-Yong Chung, Jae-Hoon Kim, et al.
Journal of Pathology Informatics
|
August 23, 2013
Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer
Tyler Keay, Catherine M Conway, Neil O'Flaherty, et al.
Technology
|
June 2, 2015
Stain-less staining for computed histopathology
David Mayerich, Michael J Walsh, Andre Kadjacsy-Balla, et al.
Leukemia & Lymphoma
|
January 1, 2015
Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood
Carsten Hirt, M Constanza Camargo, Kelly J Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development
George Poste, David P Carbone, David R Parkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2015
CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma
Mary E Olanich, Wenyue Sun, Stephen M Hewitt, et al.
Page
of 42